2021
DOI: 10.1111/cas.15113
|View full text |Cite|
|
Sign up to set email alerts
|

Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA‐152‐3p and regulating E2F3/MAPK8 signaling

Abstract: Colorectal cancer (CRC) is a common malignant tumor. 1 In recent decades, diagnosis and treatment technology has made great progress; the 5-year survival rate for CRC in the localized stage is now 90.1%. However, only 39% of CRC cases are detected in the localized stage, 2,3 and the 5-year survival rate in distant metastasis cases is 69.2%. Therefore, recent research has focused on the pathogenesis of CRC and more effective strategies for the early diagnosis and treatment of CRC. [4][5][6]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 27 publications
0
11
0
Order By: Relevance
“…Therefore, targeting JNKs by small molecular kinase inhibitors may be a novel therapeutic strategy for cancer treatments [ 53 , 54 ]. Researchers have found that the long noncoding RNA PVT1 may promote CRC progression by regulating the E2F3/MAPK8 pathways in CRC [ 55 ]. It has been reported that the MAPK pathways are located downstream of many growth-factor receptors, and overexpression and activation of MAPK may play an important role in CRC progression [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, targeting JNKs by small molecular kinase inhibitors may be a novel therapeutic strategy for cancer treatments [ 53 , 54 ]. Researchers have found that the long noncoding RNA PVT1 may promote CRC progression by regulating the E2F3/MAPK8 pathways in CRC [ 55 ]. It has been reported that the MAPK pathways are located downstream of many growth-factor receptors, and overexpression and activation of MAPK may play an important role in CRC progression [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…IL-1B, as a member of the interleukin family, is closely related to tumor immunity [ 37 ]. SOD2 contributes to the chemical resistance of colorectal cancer [ 38 ], and according to research, MAPK8 can promote the progression of colorectal cancer [ 39 ]. However, the functional roles of CARS2, GPX1, MRPL44, MTFMT, NOS1, and OSGIN2 in CRC are still unknown.…”
Section: Discussionmentioning
confidence: 99%
“…MAPK family serves as an important role in the progression of multiple tumors. The studies have indicated that increased MAPK8 plays a critical role in the development of colorectal cancer, and MAPK14 downregulation could effectively impede the poor behaviors of the clear cell renal cell carcinoma [ 25 , 26 ]. Increasing studies have revealed that the disorder of the RAS oncogene family was related with the progression of tumor.…”
Section: Discussionmentioning
confidence: 99%